Additional file 1: of Identification of barriers and facilitators for optimal cesarean section care: perspective of professionals

Interview guide. Description of the framework of the interviews. (DOC 42 kb

Distribution of patient across the baseline T/QRS values.

<p>For each initial baseline T/QRS value encountered in our data set, we counted the number of patients with that particular baseline, showing a non-symmetric distribution with the most frequent encountered baseline T/QRS ratio at 0.12.</p

The number of ST events per 1000 T/QRS values as a function of the initial baseline T/QRS value.

<p>Cases with the same initial baseline T/QRS were grouped. The intensity of the black colour of the data points relates to the total number of T/QRS ratios that occurred in the group (right column in the graph). The red line represents a linear fit through the data points. There is an average increment of 1.42 ST events per 1000 T/QRS values for a rise of 0.1 of the initial baseline T/QRS. The correlation coefficient between data points and fit was 0.63 (p <0.001), as calculated with the linear regression model.</p

Baseline characteristics of the included patients.

<p>Baseline characteristics of the included patients.</p

A randomised clinical trial on cardiotocography plus fetal blood sampling versus cardiotocography plus ST-analysis of the fetal electrocardiogram (STAN) for intrapartum monitoring-0

<p><b>Copyright information:</b></p><p>Taken from "A randomised clinical trial on cardiotocography plus fetal blood sampling versus cardiotocography plus ST-analysis of the fetal electrocardiogram (STAN) for intrapartum monitoring"</p><p>http://www.biomedcentral.com/1471-2393/7/13</p><p>BMC Pregnancy and Childbirth 2007;7():13-13.</p><p>Published online 26 Jul 2007</p><p>PMCID:PMC1976105.</p><p></p

A randomised clinical trial on cardiotocography plus fetal blood sampling versus cardiotocography plus ST-analysis of the fetal electrocardiogram (STAN) for intrapartum monitoring-1

<p><b>Copyright information:</b></p><p>Taken from "A randomised clinical trial on cardiotocography plus fetal blood sampling versus cardiotocography plus ST-analysis of the fetal electrocardiogram (STAN) for intrapartum monitoring"</p><p>http://www.biomedcentral.com/1471-2393/7/13</p><p>BMC Pregnancy and Childbirth 2007;7():13-13.</p><p>Published online 26 Jul 2007</p><p>PMCID:PMC1976105.</p><p></p

Neonatal treatments.

a<p>Percentages given according to available data.</p>b<p>Mean treatment length calculated for neonates receiving each antibiotic.</p>c<p>Mean difference with 95% CI.</p>d<p>Mean treatment length calculated from neonates receiving each treatment.</p><p>NA, not applicable; SD, standard deviation.</p

Maternal outcomes.

<p>Data are presented as number (percent).</p>a<p>Percents, RRs, 95% CIs, and <i>p</i>-values given are related to available data per characteristic and may differ from the total number of patients.</p>b<p>Outcome characteristic with more than 5% missing data. Histological chorioamnionitis data available for 396 women (74%); histological funisitis data available for 388 women (73%).</p

Trial profile.

<p>Trial profile.</p

Kaplan-Meier curve for the interval between randomization and birth.

<p>Kaplan-Meier curve for the interval between randomization and birth.</p